MAP
AMPH icon

Moody Aldrich Partners’s Amphastar Pharmaceuticals AMPH Stock Holding History

Moody Aldrich Partners’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-100,340
Closed -$4.87M – 200
2024
Q3 		$4.87M Buy
100,340
+44,606
+80% +$1.96M 0.89% 48
2024
Q2 		$2.23M Sell
55,734
-19,744
-26% -$818K 0.43% 87
2024
Q1 		$3.31M Buy
75,478
+12,364
+20% +$639K 0.56% 79
2023
Q4 		$3.9M Buy
+63,114
New +$3.32M 0.7% 64

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Moody Aldrich Partners's AMPH Position: Q4 2024 in Review

Moody Aldrich Partners sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2024, closing a stake of 100,340 shares — an estimated $4.87M sold.

Moody Aldrich Partners first reported a position in AMPH in Q4 2023 and held it in 4 quarters. The position peaked at $4.87M in Q3 2024. 263 funds tracked by Wall St. Rank hold AMPH as of Q4 2024.

  • Moody Aldrich Partners reported no remaining Amphastar Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Moody Aldrich Partners sold 100,340 Amphastar Pharmaceuticals shares in Q4 2024, an estimated $4.87M.
  • Moody Aldrich Partners first reported a position in Amphastar Pharmaceuticals in Q4 2023 and held it in 4 quarters.
  • Moody Aldrich Partners's Amphastar Pharmaceuticals position peaked at $4.87M in Q3 2024.
  • 263 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2024.

Based on Moody Aldrich Partners's 13F filing for Q4 2024, filed 23 Jan 2025.